DE69132813D1 - Genetisches igfbp-5 rodierendes material - Google Patents

Genetisches igfbp-5 rodierendes material

Info

Publication number
DE69132813D1
DE69132813D1 DE69132813T DE69132813T DE69132813D1 DE 69132813 D1 DE69132813 D1 DE 69132813D1 DE 69132813 T DE69132813 T DE 69132813T DE 69132813 T DE69132813 T DE 69132813T DE 69132813 D1 DE69132813 D1 DE 69132813D1
Authority
DE
Germany
Prior art keywords
protein
dna molecules
binding
igfbp
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69132813T
Other languages
English (en)
Other versions
DE69132813T2 (de
Inventor
C Kiefer
Frank Masiarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of DE69132813D1 publication Critical patent/DE69132813D1/de
Application granted granted Critical
Publication of DE69132813T2 publication Critical patent/DE69132813T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69132813T 1990-08-28 1991-08-28 Genetisches igfbp-5 rodierendes material Expired - Fee Related DE69132813T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57461390A 1990-08-28 1990-08-28
US57739290A 1990-08-31 1990-08-31
PCT/US1991/006140 WO1992003470A1 (en) 1990-08-28 1991-08-28 Genetic material encoding igfbp-5

Publications (2)

Publication Number Publication Date
DE69132813D1 true DE69132813D1 (de) 2002-01-03
DE69132813T2 DE69132813T2 (de) 2002-06-27

Family

ID=27076438

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132813T Expired - Fee Related DE69132813T2 (de) 1990-08-28 1991-08-28 Genetisches igfbp-5 rodierendes material

Country Status (8)

Country Link
EP (1) EP0546074B1 (de)
JP (1) JPH06503947A (de)
AT (1) ATE208815T1 (de)
CA (1) CA2090705A1 (de)
DE (1) DE69132813T2 (de)
IE (1) IE913035A1 (de)
PT (1) PT98806B (de)
WO (1) WO1992003470A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333063T2 (de) 1992-11-04 2004-05-13 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Vekürztes insulinähnlichen wachstumsfaktor-bindendes protein mit mitogener aktivität
US5712381A (en) 1994-10-19 1998-01-27 Genetics Institute, Inc. MADD, a TNF receptor death domain ligand protein
US5847099A (en) * 1994-10-19 1998-12-08 Genetics Institute, Inc. TNF receptor death domain ligand proteins
US5852173A (en) * 1994-10-19 1998-12-22 Genetics Institute, Inc. TNF receptor death ligand proteins and inhibitors of ligand binding
US5849501A (en) * 1994-10-19 1998-12-15 Genetics Institute, Inc. TNF receptor death domain ligand proteins and method to identify inhibitors of ligand binding
DK1486565T3 (da) 1995-10-11 2008-03-10 Novartis Vaccines & Diagnostic Kombination af PDGF, KGF, IGF og IGFBP til sårheling
EP1867719A3 (de) * 1999-06-02 2008-03-19 Genentech, Inc. Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums
US7491816B2 (en) 1999-07-19 2009-02-17 The University Of British Columbia Antisense therapy for hormone-regulated tumors
EP1200579B1 (de) 1999-07-19 2008-04-23 The University of British Columbia Antisense-therapie für hormonregulierte tumoren
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
US6750019B2 (en) 2001-10-09 2004-06-15 Isis Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
AU2002334895B2 (en) 2001-10-09 2006-10-19 Isis Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
NZ533126A (en) 2002-01-17 2006-04-28 Univ British Columbia Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
WO2005030260A1 (en) 2003-10-01 2005-04-07 The University Of British Columbia Bispecific oligonucleotide for the treatment of cns malignancies
EP1670822A2 (de) 2003-10-03 2006-06-21 Genentech, Inc. Igf-bindende proteine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds

Also Published As

Publication number Publication date
PT98806B (pt) 1999-01-29
EP0546074A4 (en) 1994-08-17
WO1992003470A1 (en) 1992-03-05
IE913035A1 (en) 1992-03-11
EP0546074A1 (de) 1993-06-16
PT98806A (pt) 1992-08-31
CA2090705A1 (en) 1992-03-01
ATE208815T1 (de) 2001-11-15
JPH06503947A (ja) 1994-05-12
DE69132813T2 (de) 2002-06-27
EP0546074B1 (de) 2001-11-14

Similar Documents

Publication Publication Date Title
DE69132814T2 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
DE69132813T2 (de) Genetisches igfbp-5 rodierendes material
KR890006668A (ko) 폴리펩티드
KR910700257A (ko) 상피 세포에 특이적인 성장인자를 암호하는 dna
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
EP1006182A3 (de) Polypeptidfragmente des Faktors-VIIIc, zu den entsprechenden Sonden und DNA-Sequenzen und DNA-Konstruktionen
ATE189700T1 (de) Genetisches igfbp-4 rodierendes material
Ho et al. Purification and properties of a transcriptional activator. The cII protein of phage lambda.
ATE135403T1 (de) Herstellung und reinigung eines proteins, das mit einem bindungsprotein fusioniert ist
Yamamura et al. High mobility group-like protein in bovine milk stimulates the proliferation of osteoblastic MC3T3-E1 cells
ATE290087T1 (de) Neue signalsequenzen
KR870001311A (ko) 단백질 및 폴리펩티드의 제조 방법
ATE247164T1 (de) Insulinartigen wachstumsfaktor bindendes protein
CA2230111A1 (en) Antisecretory factor peptides regulating pathological permeability changes
ATE286069T1 (de) Verfahren zur herstellung rekombinanter pilc- proteine
RU2005123689A (ru) Флуоресцирующие белки из веслоногих ракообразных и способы их применения
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
WO1995008628A3 (en) Nucleic acids encoding merosin, merosin fragments and uses thereof
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung
Wuyts et al. Purification and identification of human and mouse granulocyte chemotactic protein-2 isoforms
Goodman et al. Collagen preservation in soft tissue from the Magadan mammoth
KR930701464A (ko) 이질성 단백질의 생성용 스트렙토마이세스 벡터
DE50015410D1 (de) Nukleinsäuremolekül, umfassend eine für ein hämocyanin kodierende nukleinsäuresequenz und mindestens eine intronsequenz
Chestukhina et al. Amino acid sequences from the N-terminal domain of Bacillus thuringiensis, subspecies alesti, δ-endotoxin: Hypervariable regions of Bacillus thuringiensis δ-endotoxms

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US

8339 Ceased/non-payment of the annual fee